Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis
Jaiwoo Lee, Junho Byun, Gayong Shim, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Fabrication of active targeting lipid nanoparticles: Challenges and perspectives
Ipshita Menon, Maryam Zaroudi, Yuanzhe Zhang, et al.
Materials Today Advances (2022) Vol. 16, pp. 100299-100299
Closed Access | Times Cited: 80
Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Bruno Cogliati, Chittampalli Yashaswini, Shuang Wang, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 647-661
Open Access | Times Cited: 64
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 57
Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 50
Vicious Cycle‐Breaking Lipid Nanoparticles Remodeling Multicellular Crosstalk to Reverse Liver Fibrosis
Lingfeng Zhang, Wen‐Qi Deng, Qing‐Wen Huang, et al.
Advanced Materials (2024) Vol. 36, Iss. 16
Closed Access | Times Cited: 17
Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
Jie Liu, Jinhu Liu, Weiwei Mu, et al.
ACS Nano (2024) Vol. 18, Iss. 32, pp. 20861-20885
Closed Access | Times Cited: 14
Aptamer-modified melittin micelles efficiently inhibit osteosarcoma deterioration by inducing immunogenic cell death
Siyu Jia, Yaohui Chen, Chao Zhuo, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114512-114512
Closed Access | Times Cited: 1
Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum
Juhyeong Hong, Yong‐Hee Kim
Journal of Controlled Release (2025) Vol. 380, pp. 433-456
Closed Access | Times Cited: 1
Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets
Yutong Li, Mawieh Hamad, Eyad Elkord
Hepatology International (2025)
Closed Access | Times Cited: 1
Comparative Proteomics Inspired Self‐Stimulated Release Hydrogel Reinforces the Therapeutic Effects of MSC‐EVs on Alzheimer's Disease
Meng Huang, Mengna Zheng, Qingxiang Song, et al.
Advanced Materials (2023) Vol. 36, Iss. 14
Closed Access | Times Cited: 20
An activatable near-infrared molecular reporter for fluoro-photoacoustic imaging of liver fibrosis
Minqian Miao, Jia Miao, Yuan Zhang, et al.
Biosensors and Bioelectronics (2023) Vol. 235, pp. 115399-115399
Closed Access | Times Cited: 16
Nanomaterials for Targeting Liver Disease: Research Progress and Future Perspectives
Yinghua Wu, Junfeng Zhang, Wen He, et al.
Nano Biomedicine and Engineering (2023) Vol. 15, Iss. 2, pp. 199-224
Open Access | Times Cited: 14
Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells?
Nataliya Basalova, Natalya Alexandrushkina, Olga Grigorieva, et al.
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1718-1718
Open Access | Times Cited: 14
Nanomodulator-Mediated Restructuring of Adipose Tissue Immune Microenvironments for Antiobesity Treatment
Qiaoyun Li, Junho Byun, Jaehyun Choi, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9311-9330
Closed Access | Times Cited: 6
Non-invasive visualization of liver fibrosis with [68Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation
Yangmeihui Song, Chunxia Qin, Yixiong Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3572-3584
Closed Access | Times Cited: 5
Peptide‐Based Nanoarchitectonics for the Treatment of Liver Fibrosis
Bowen Li, Yan Huang, Qianli Zou
ChemBioChem (2023) Vol. 24, Iss. 9
Closed Access | Times Cited: 13
Selective inhibition of glycolysis in hepatic stellate cells and suppression of liver fibrogenesis with vitamin A-derivative decorated camptothecin micelles
Xiang Li, Xin Wang, Qiangqiang Jiao, et al.
Acta Biomaterialia (2023) Vol. 168, pp. 497-514
Open Access | Times Cited: 12
RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment
Xinzhu Shan, Zhiqiang Zhao, Pingping Lai, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Targeting fibroblast activation protein with chimeric antigen receptor macrophages
Yizhi Mao, Yao Chen, Shimeng Zhang, et al.
Biochemical Pharmacology (2024) Vol. 230, pp. 116604-116604
Closed Access | Times Cited: 4
Targeting Cardiac Fibrosis With a Vaccine Against Fibroblast Activation Protein
William M. Oldham
Circulation Research (2025) Vol. 136, Iss. 1, pp. 41-43
Closed Access
Glycyrrhizinate Monoammonium Cysteine-Loaded Lipid Nanoparticles Allow for Improved Acute Liver Injury Therapy
Yunjie Xu, Pinghui Li, Shiran Sun, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 90-90
Open Access
Sono-mediated glutamine metabolic nanoplatform against liver fibrosis via breaking the vicious self-injury of activated hepatic stellate cells
Peng Yang, Weijing Liu, Zhuang Chen, et al.
Nano Today (2025) Vol. 61, pp. 102641-102641
Closed Access
Synthesis and application of astaxanthin-loaded procyanidins/sea cucumber peptide nanoparticles with good antioxidant and pH-responsive capacities
Shasha Huang, Zheng Hua, Kuiyou Wang, et al.
Food Research International (2025) Vol. 203, pp. 115821-115821
Closed Access
Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical Translation
Hao Xiong, Guo J
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 507-507
Open Access
Antifibrotic Therapies for Metabolic Dysfunction-associated Steatotic Liver Disease
Robert F. Schwabe, Frank Tacke, Atsushi Sugimoto, et al.
JHEP Reports (2025), pp. 101421-101421
Open Access
Page 1 - Next Page

Scroll to top